Highbridge Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-35,700
Closed -$1.99M 101
2020
Q2
$1.99M Buy
+35,700
New +$2.06M 0.17% 61
2018
Q2
Sell
-122,103
Closed -$6.38M 1409
2018
Q1
$6.38M Buy
+122,103
New +$6.19M 0.1% 242
2017
Q4
Sell
-8,800
Closed -$488K 2054
2017
Q3
$488K Sell
8,800
-86,831
-91% -$5.75M 0.01% 936
2017
Q2
$7.36M Buy
+95,631
New +$7.15M 0.11% 232
2016
Q2
Sell
-91,476
Closed -$4.45M 1834
2016
Q1
$4.45M Buy
+91,476
New +$4.15M 0.07% 309
2015
Q3
Sell
-17,376
Closed -$823K 1887
2015
Q2
$823K Sell
17,376
-60,775
-78% -$2.84M 0.01% 785
2015
Q1
$3.59M Buy
+78,151
New +$3.63M 0.05% 395
2014
Q3
Sell
-26,893
Closed -$957K 1416
2014
Q2
$957K Buy
26,893
+17,178
+177% +$588K 0.01% 579
2014
Q1
$373K Buy
+9,715
New +$357K ﹤0.01% 784
2013
Q3
Sell
-52,101
Closed -$1.29M 1575
2013
Q2
$1.29M Buy
+52,101
New +$1.14M 0.01% 604

Other funds holding NUVA

Highbridge Capital Management's NUVA Position: Q3 2020 in Review

Highbridge Capital Management sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 35,700 shares — an estimated $1.99M sold.

Highbridge Capital Management first reported a position in NUVA in Q2 2013 and held it in 10 quarters. The position peaked at $7.36M in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

  • Highbridge Capital Management reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
  • Highbridge Capital Management sold 35,700 NuVasive, Inc. shares in Q3 2020, an estimated $1.99M.
  • Highbridge Capital Management first reported a position in NuVasive, Inc. in Q2 2013 and held it in 10 quarters.
  • Highbridge Capital Management's NuVasive, Inc. position peaked at $7.36M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on Highbridge Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.